Recent Progress in the Identification of Early Transition Biomarkers from Relapsing-Remitting to Progressive Multiple Sclerosis

Recent Progress in the Identification of Early Transition Biomarkers from Relapsing-Remitting to Progressive Multiple Sclerosis

Despite extensive research into the pathophysiology of multiple sclerosis (MS) and recent developments in potent disease-modifying therapies (DMTs), two-thirds of relapsing-remitting MS patients transition to progressive MS (PMS). The main pathogenic mechanism in PMS is represented not by inflammati...

Full description

Bibliographic Details
Main Authors: Smaranda Maier, Laura Barcutean, Sebastian Andone, Doina Manu, Emanuela Sarmasan, Zoltan Bajko, Rodica Balasa
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:International Journal of Molecular Sciences
Subjects:
multiple sclerosis
neurodegeneration
relapsing-remitting
secondary progressive
progression
biomarker
Online Access:https://www.mdpi.com/1422-0067/24/5/4375

Internet

https://www.mdpi.com/1422-0067/24/5/4375

Similar Items